A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
NCT01264133 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2014-12-18
Summary
An open study to Evaluate the Efficacy, Safety and Sustained effect of Clevudine monotherapy or Adefovir and Clevudine combination in proportion to Roadmap concept in Patients with chronic hepatitis B.
Conditions
Interventions
- DRUG
-
Clevudine, Adefovir
Clevudine 30mg qd or Clevudine 30mg + Adefovir 10mg qd
Sponsors & Collaborators
-
Bukwang Pharmaceutical
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2013-06-30
- Completion
- 2014-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
NCT01264094 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
NCT00362505 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
NCT00044135 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
NCT00798460 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
NCT01266005 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
NCT00362700 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
NCT01264367 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
NCT00672867 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
NCT00313261 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
NCT00496158 ·Status: TERMINATED ·Phase: PHASE3
-
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
NCT00823342 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
NCT00305019 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
NCT00313287 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
NCT00496002 ·Status: TERMINATED ·Phase: PHASE3
-
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
NCT00558493 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
NCT00313274 ·Status: TERMINATED ·Phase: PHASE3
-
An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine
NCT01264107 ·Status: COMPLETED
-
An Study of Efficacy and Safety of Clevudine
NCT01192854 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
NCT00362635 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)
NCT01205165 ·Status: COMPLETED ·Phase: PHASE4
-
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00467545 ·Status: COMPLETED ·Phase: PHASE4
-
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
NCT07307586 ·Status: RECRUITING ·Phase: PHASE3
-
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
NCT00531167 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
NCT00403585 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV
NCT00645294 ·Status: COMPLETED ·Phase: PHASE1/PHASE2